What is the main business of Omega Lasmed?

The main business activity of Omega Lasmed focuses on manufacture of irradiation, electromedical and electrotherapeutic equipment.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 31, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Zapłocie 8, 02-970 Warszawa.

Who is on the management board?

The management board consists of: Adam Eryk Kazimierczuk (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $204.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $2,897. For comparison, in 2023 the loss was $2,902, meaning the company reduced its loss by 5.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $191 in 2024, representing 46% of all operating expenses.

Omega LasmedS.A.

Manufacture of irradiation, electromedical and electrotherapeutic equipment

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-12-31

Share capital

100 000,00 PLN

Activity description

Omega Lasmed is a provider of laser medical technology, offering products such as BV lasers, Gigaa lasers, Jonte lasers, and Kernel MEDlight. The company specializes in applications across various medical fields, including dermatology, aesthetics, gynecology, and surgery. They also provide services like free delivery, training for operators, and regular safety checks for medical devices.

Registered address

ul. Zapłocie 8, 02-970 Warszawa, Poland

Website

lasmed.eu

Phone

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 203.71MedianUSD 103.37kAverageUSD 1.78m

Net profit

This companyUSD -2.90kMedianUSD -472.34AverageUSD 120.51k

Operating costs

This companyUSD 416.66MedianUSD 151.45kAverageUSD 1.57m

Assets

This companyUSD 192.90kMedianUSD 283.83kAverageUSD 2.08m

Industry

Bank accounts

Registered as a VAT taxpayer on 2015-02-20. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication date	Event
Mar 8, 2021	Transformation registered

Public aid

23 public aid cases recorded, with a total value of $185,111.

Grant date	Purpose	Gross amount	Granting body
Jan 10, 2020	Aid in the form of wage subsidies for the recruitment of workers with disabilities	$236$236	Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych
Jul 5, 2019	Aid in the form of wage subsidies for the recruitment of workers with disabilities	$199$199	Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych
Jun 14, 2019	Aid in the form of wage subsidies for the recruitment of workers with disabilities	$445$445	Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych

European Funds

Start	Project	EU co-financing	Programme
2017-01-05	Opracowanie nowej generacji lasera CO2	$132.8K$132,785	Regionalny Program Operacyjny Województwa Mazowieckiego na lata 2014-2020

Tenders

No recorded participation in tenders.

Authorized Representatives

Adam Eryk Kazimierczuk — President of the Management Board

Manner of representation

The method of representation of the company is as follows: a) in the case of a one-person management board, a member of the management board is authorized to submit declarations on behalf of the company independently; b) in the case of a multi-member management board, joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to submit declarations on behalf of the company.

Supervisory board

Piotr Dobrzyński — Supervisory Board Member

Tomasz Henryk Krupa — Supervisory Board Member

Mirosław Sławomir Nowicki — Supervisory Board Member

Beneficial owners

Person	Rights
Mirosław Nowicki (60)	Shareholder of a joint-stock company, 27.6%
Mirosław Sławomir Nowicki (60)	Poprzez lasmed sp.z o.o. krs 0000534373

Competitors

	Name	Revenue	Website
	Inneximsp. z o.o.	$145.90	innexim.pl

FAQ

Last updated: 2026-03-31